or
forgot password
  • cancer clinical trials in tucson, AZ

  • Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
    Arizona Cancer Center at University Medical Center North
    Tucson, Arizona 85719
    Cognitive/Functional Effects, Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Connect® MM- The Multiple Myeloma Disease Registry
    US Oncology - Arizona Oncology Associates - Rudasill
    Tucson, Arizona 85704
    Multiple Myeloma
    Sorafenib Tosylate and Erlotinib Hydrochloride in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gallbladder Cancer or Cholangiocarcinoma
    University of Arizona Health Sciences Center
    Tucson, Arizona 85724
    Adenocarcinoma of the Extrahepatic Bile Duct, Adenocarcinoma of the Gallbladder, Adenocarcinoma With Squamous Metaplasia of the Gallbladder, Anaplastic Carcinoma of the Gallbladder, Cholangiocarcinoma of the Extrahepatic Bile Duct, Cholangiocarcinoma of the Gallbladder, Recurrent Extrahepatic Bile Duct Cancer, Recurrent Gallbladder Cancer, Unresectable Extrahepatic Bile Duct Cancer, Unresectable Gallbladder Cancer
    S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
    Arizona Cancer Center at University of Arizona Health Sciences Center

    Trial Locations
    Arizona Cancer Center at University of Arizona Health Sciences Center
    Arizona Cancer Center at University Medical Center North
    brca1 Mutation Carrier, brca2 Mutation Carrier, Breast Cancer
    A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer
    University of Arizona Health Sciences Center

    Trial Locations
    University of Arizona Health Sciences Center
    Arizona Cancer Center at University Medical Center North
    Breast Cancer
    Comprehensive Oncology Measures for Peripheral T-cell Lymphoma Treatment Registry
    Arizona Cancer Center
    Tucson, Arizona 85724
    Peripheral T-cell Lymphoma
    An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+
    Visions Clinical Research - Tucson
    Tucson, Arizona 85712
    Cervical Intraepithelial Neoplasia
    Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Stage IV Melanoma
    University of Arizona Health Sciences Center
    Tucson, Arizona 85724
    Acral Lentiginous Malignant Melanoma, Lentigo Maligna Malignant Melanoma, Nodular Malignant Melanoma, Recurrent Melanoma, Solar Radiation-related Skin Melanoma, Stage IV Melanoma, Superficial Spreading Malignant Melanoma
    Chemotherapy Based on Positron Emission Tomography Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma
    Arizona Cancer Center at University of Arizona Health Sciences Center
    Tucson, Arizona 85724
    Lymphoma
    Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    Arizona Cancer Center at University of Arizona Health Sciences Center
    Tucson, Arizona 85724
    Leukemia
    Study of the Safety and Efficacy of TH-302 in Combination With Gemcitabine Compared With Gemcitabine Alone in Previously Untreated Patients With Pancreatic Adenocarcinoma
    University of Arizona

    Trial Locations
    University of Arizona
    Arizona Oncology Associates, PC - HOPE
    Pancreatic Adenocarcinoma
    Efficacy Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Platinum-Refractory Head and Neck Cancers
    Arizona Oncology Associates
    Tucson, Arizona 85712-2254
    Carcinoma, Squamous Cell of the Head and Neck
    Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    University of Arizona Health Sciences Center

    Trial Locations
    University of Arizona Health Sciences Center
    Arizona Cancer Center at University Medical Center North
    Arizona Cancer Center at UMC Orange Grove
    Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIA Primary Peritoneal Cavity Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIB Primary Peritoneal Cavity Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIC Primary Peritoneal Cavity Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer
    Pemetrexed Disodium and Docetaxel in Treating Patients With Advanced Solid Tumors
    Arizona Cancer Center at University of Arizona Health Sciences Center
    Tucson, Arizona 85724
    Breast Cancer, Esophageal Cancer, Gastric Cancer, Head and Neck Cancer, Lung Cancer, Ovarian Cancer, Prostate Cancer
    A Study of IMC-3G3 in Soft Tissue Sarcoma
    ImClone Investigational Site
    Tucson, Arizona 85712
    Sarcoma, Soft Tissue
    Risk-Adapted Chemotherapy in Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia
    University of Arizona Health Sciences Center
    Tucson, Arizona 85724
    B-cell Childhood Acute Lymphoblastic Leukemia, Philadelphia Chromosome Positive Childhood Precursor Acute Lymphoblastic Leukemia, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
    PALACE 3: Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis
    Catalina Pointe Clinical Research Incorporated
    Tucson, Arizona 85704
    Psoriatic Arthritis
    Avoiding the Hippocampus During Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
    Arizona Cancer Center at University of Arizona Health Sciences Center

    Trial Locations
    Arizona Cancer Center at University of Arizona Health Sciences Center
    Arizona Oncology - Tucson
    Cognitive/Functional Effects, Metastatic Cancer, Unspecified Adult Solid Tumor, Protocol Specific
    Phase III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Relapsed or Refractory Multiple Myeloma
    ACRC/Arizona Clinical Research Center, Inc.
    Tucson, Arizona 85712
    Multiple Myeloma
    Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
    Arizona Oncology Associates, PC - HOPE
    Tucson, Arizona 85704
    Chronic Myeloid Leukemia
    Akt Inhibitor MK2206 in Treating Patients With Advanced Gastric or Gastroesophageal Junction Cancer
    University of Arizona Health Sciences Center

    Trial Locations
    University of Arizona Health Sciences Center
    Arizona Cancer Center at University Medical Center North
    Arizona Cancer Center at UMC Orange Grove
    Adenocarcinoma of the Gastroesophageal Junction, Adenocarcinoma of the Stomach, Recurrent Esophageal Cancer, Recurrent Gastric Cancer
    Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery
    Arizona Cancer Center at University Medical Center North

    Trial Locations
    Arizona Cancer Center at University Medical Center North
    Arizona Cancer Center at UMC Orange Grove
    Recurrent Melanoma, Stage IIIB Melanoma, Stage IIIC Melanoma, Stage IV Melanoma
    A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
    Urology Associates of Southern Arizona
    Tucson, Arizona 85741
    Prostatic Neoplasms
    NP2 Enkephalin For Treatment of Intractable Cancer Pain
    Arizona Clinical Research Center
    Tucson, Arizona 85712
    Intractable Pain, Neoplasms
    A Study to Investigate the Safety and Efficacy of AT13387, Alone or in Combination With Imatinib, in Patients With GIST
    Arizona Cancer Center at UMC North
    Tucson, Arizona 85719
    Gastrointestinal Stromal Tumor (GIST)
    A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
    Genova Clinical Research
    Tucson, Arizona 85741
    Overactive Bladder
    A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
    Urological Associates of Southern Arizona, P.C.

    Trial Locations
    Urological Associates of Southern Arizona, P.C.
    Arizona Oncology Associates, PC - HOPE
    Arizona Institute of Urology
    Advanced Prostate Cancer, Prostatic Neoplasms
    Comparison of Pixantrone + Rituximab With Gemcitabine + Rituximab in Patients With Aggressive B-cell Non-Hodgkin Lymphoma or Follicular Grade 3 Lymphoma Who Have Relapsed After Therapy and Are Not Eligible for Stem Cell Transplant
    Arizona Oncology Associates
    Tucson, Arizona 85712-2254
    Diffuse Large B-cell Lymphoma, de Novo DLBCL, DLBCL Transformed From Indolent Lymphoma, Follicular Grade 3 Lymphoma
    A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma
    Site Reference ID/Investigator# 52902
    Tucson, Arizona 85724-5024
    Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma
    E7050 in Combination With Cetuximab Versus Cetuximab Alone in the Treatment of Platinum-Resistant Squamous Cell Carcinoma of the Head and Neck
    Arizona Oncology Associates, PC - CASA
    Tucson, Arizona 85715
    Platinum-Resistant Squamous Cell Carcinoma of the Head and Neck
    Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer
    Synta Pharmaceuticals Investigative Site
    Tucson, Arizona 85715
    Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV, Non-small Cell Lung Cancer Metastatic
    Higher Per Daily Treatment-Dose Radiation Therapy or Standard Per Daily Treatment Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by Surgery
    University of Arizona Health Sciences Center

    Trial Locations
    University of Arizona Health Sciences Center
    Arizona Oncology Associates-West Orange Grove
    Breast Cancer
    S0820, Adenoma and Second Primary Prevention Trial
    Arizona Cancer Center at UMC Orange Grove
    Tucson, Arizona 85704
    Colorectal Neoplasms
    A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
    University of Arizona Medical Center - Tucson
    Tucson, Arizona 85224
    Hematological Malignancies, Certain Lysosomal Storage and Peroxisomal Enzyme Deficiency Disorders, Hurler Syndrome (MPS I), Krabbe Disease (Globoid Leukodystrophy), X-linked Adrenoleukodystrophy, Primary Immunodeficiency Diseases, Bone Marrow Failure, Beta-thalassemia
    Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia
    University of Arizona (SPORE)
    Tucson, Arizona 85719
    B Cell Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, Waldenstrom Macroglobulinemia
    PET-Directed Therapy in Treating Patients With Limited-Stage Diffuse Large B-Cell Lymphoma
    Arizona Cancer Center at University of Arizona Health Sciences Center
    Tucson, Arizona 85724
    Lymphoma
    A Double-blind Study Evaluating IPI-504 and Docetaxel in Patients With Non-Small Cell Lung Cancer
    Arizona Oncology Associates
    Tucson, Arizona 85712-2254
    Non Small Cell Lung Cancer
    Chemotherapy Toxicity On Quality of Life in Older Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer
    Arizona Cancer Center at University Medical Center North
    Tucson, Arizona 85719
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Resveratrol in Postmenopausal Women With High Body Mass Index
    University of Arizona Health Sciences Center
    Tucson, Arizona 85724
    Healthy, no Evidence of Disease